At QuidelOrtho, we are committed to conducting our business in accordance with all applicable laws, rules, and regulations, and the highest ethical standards. This section includes documents regarding the Company's corporate governance practices, evidencing the Company's commitment to sound principles of corporate governance.

QuidelOrtho’s Comprehensive Compliance Program, Code of Business Conduct and Ethics, and Annual Written Declaration may be obtained by calling 800-874-1517.

Board of Directors

Kenneth F. Buechler, Ph.D., Chairman of QuidelOrtho Corporation
Founder And Former President, Chief Scientific Officer Of Biosite, Inc.

Evelyn S. Dilsaver, Former President And CEO Of Charles Schwab Investment Management

Edward L. Michael, Managing Partner And Co-founder Of Lionbird Ventures
Former Executive Vice President, Diagnostic Products Of Abbott Laboratories

Mary Lake Polan, M.D., Ph.D., M.P.H., Professor Of Clinical Obstetrics, Gynecology And Reproductive Sciences Of Yale University School of Medicine

Jim R. Prutow, Operating Executive Of The Carlyle Group

Ann D. Rhoads, Former Chief Financial Officer of Forty Seven, Inc.

Robert R. Schmidt, Managing Director Of The Carlyle Group

Matthew W. Strobeck, Ph.D., Managing Partner of Birchview Capital

Kenneth J. Widder, M.D., Chief Executive Officer of Sydnexis Inc.

Joseph D. Wilkins Jr., Managing Director, JW Healthcare Insights
Former Executive Of Atlantic Health System, Quest Diagnostics, And Danaher-beckman Coulter

Committee Composition

Board Diversity Matrix

As of February 27, 2024

Total Number of Directors 10
  Female Male Non-Binary Did Not Disclose Gender
Part I: Gender Identity:
Directors 3 6 1
Part II: Demographic Background:
African American or Black 1
Alaskan Native or American Indian
Asian  1
Hispanic or Latinx
Native Hawaiian or Pacific Islander
White 2 5
Two or More Races or Ethnicities
Did Not Disclose Demographic Background 1


Quidel does not undertake any animal testing or outsource any animal testing to any third party.